Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0278126 (
loss of equilibrium
)
140
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A series of experiments were conducted to determine the physiological impact of acute sublethal
molybdenum
exposure to juvenile kokanee salmon (Oncorhynchus nerka Kennerlyi).
Molybdenum
was found to be relatively non-toxic to kokanee as the 96 h LC(50) was greater than 2,000 mg Mo l(-1). Exposure to either 25 or 250 mg Mo x l(-1) for 7 days was found to stimulate a significant 1.6- to 1.7-fold increase in ventilation which was later characterized to be dose-dependent between 5 and 250 mg Mo l(-1). Acute sublethal
molybdenum
exposure was found to have little or no impact on kokanee oxygen consumption at rest or immediately following a bout of forced activity or on physiological indicators of stress such as plasma lactate, sodium and cortisol. Despite these findings, prior exposure to 25 or 250 mg Mo l(-1) resulted in post-exercise
loss of equilibrium
and exercise-induced delayed mortality that were not observed in controls.
Molybdenum
accumulation in gill and liver of kokanee was also characterized. The findings of this study suggest that despite the non-toxic nature of
molybdenum
, acute sublethal exposure to this metal has physiological consequences to those fish exposed even for only a brief period. Further studies are needed to more fully elucidate the metabolism and mode of action of this metal in fish.
...
PMID:Physiological impact of acute molybdenum exposure in juvenile kokanee salmon (Oncorhynchus nerka). 1237 20